Janet Hopkins

Chief Tech/Sci/R&D Officer at AURA BIOSCIENCES, INC.

Net worth: 1 M $ as of 30/04/2024

59 year

Health Technology

Consumer Services

Janet Hopkins active positions

Companies	Position	Start	End
GYROSCOPE THERAPEUTICS HOLDINGS PLC	Director/Board Member	17/02/2022	-
AURA BIOSCIENCES, INC.	Chief Tech/Sci/R&D Officer	16/10/2023	-

Companies	Position	Start	End
NOVARTIS AG	Corporate Officer/Principal	01/11/2021	01/10/2023
Gyroscope Therapeutics Ltd. Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom.	Chief Executive Officer	01/12/2021	01/10/2023

McMaster University

Doctorate Degree

International

Operational

Director/Board Member	1
Chief Tech/Sci/R&D Officer	1
Corporate Officer/Principal	1

Sectoral

Health Technology	5
Consumer Services	2

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	2
AURA BIOSCIENCES, INC.	Health Technology
NOVARTIS AG	Health Technology

Private companies	2
Gyroscope Therapeutics Holdings Plc Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Gyroscope Therapeutics Holdings Plc engages in the development of gene therapy beyond rare diseases. It focuses on age-related macular degeneration. The company was founded in 2016 and is headquartered in Stevenage, the United Kingdom.	Health Technology
Gyroscope Therapeutics Ltd. Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom.	Health Technology